T. Rowe Price Investment Management’s Alamar Biosciences ALMR Stock Holding History

T. Rowe Price Investment Management’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.7M	Buy	+2,202,597	New	+$49.8M	0.04%	366

Other funds holding ALMR

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

T. Rowe Price Investment Management's ALMR Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 2,202,597 shares worth $59.7M. The stake represents 0.04% of the portfolio and ranks #366 among its holdings.

73 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

T. Rowe Price Investment Management held 2,202,597 shares of Alamar Biosciences worth $59.7M as of Q2 2026.
Alamar Biosciences was a new T. Rowe Price Investment Management position in Q2 2026.
Alamar Biosciences made up 0.04% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #366 holding.
73 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.